RxDoctor Payments Data

Justin Hurie, MD

Vascular Surgery · Winston Salem, NCNPI 1649431628

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $4,400 of the $6,309 with a category attached, or 69.7%. W. L. Gore & Associates, Inc. accounts for 88.9% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2020 at $5,390 and has fallen 97.4% since, to $139 in 2025.

$6,309in general payments, 2019–2025

Across 19 payments — averaging $332.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$6K
  • Silk Road Medical, Inc.$405
  • Boston Scientific$134
  • Cook Medical LLC$88
  • Terumo Medical Corporation$56
  • Johnson & Johnson$19
$31,063in research payments, 2019–2025

Across 28 payments — averaging $1109.39 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Humacyte Global, Inc.$23K
  • Cook Research Incorporated$7K
  • W. L. Gore & Associates, Inc.$960

What the payments were for

  • Consulting fees$4,40070%
  • Travel & lodging$1,07117%
  • Food & beverage$83813%

General payments by program year

19
20
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,309 in reported general payments places this provider in the 65th percentile of 119 vascular surgery providers in North Carolina.

See all vascular surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$91,032
Medicare patients
497
Services billed
637

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cilostazol18$646

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Winston Salem

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →